Vaccination in elderly patients
AssigneeCureVac AG
InventorsKarl-Josef KALLEN, Thomas KRAMPS, Margit SCHNEE, Benjamin PETSCH, Lothar STITZ
Life of this patent
Estimating the term…
Loading patent…
AssigneeCureVac AG
InventorsKarl-Josef KALLEN, Thomas KRAMPS, Margit SCHNEE, Benjamin PETSCH, Lothar STITZ
Estimating the term…
The present invention relates to vaccines comprising at least one mRNA encoding at least one antigen for use in the treatment of a disease in an elderly patient preferably exhibiting an age of at least 50 years, more preferably of at least 55 years, 60 years, 65 years, 70 years, or older, wherein the treatment comprises vaccination of the patient and eliciting an immune response in said patient. The present invention is furthermore directed to kits and kits of parts comprising such a vaccine and/or its components and to methods applying such a vaccine or kit.
Vaccine comprising at least one mRNA encoding at least one antigen for use in the prophylaxis and/or treatment of a disease in an elderly patient exhibiting an age of at least 50 years, wherein the treatment comprises vaccination of the patient and eliciting an immune response in said patient.
Kit, comprising a vaccine as defined according to any of claims 1 to 15, wherein each mRNA encoding at least one antigen is provided in a different part of the kit.
Dependencies are inferred from the claim text.